Performance of 0.55T MRI is comparable to 1.5T MRI in acquiring and interpreting late gadolinium enhancement in patients suspected of myocardial infarction, research shows.
A lower-field strength MRI can provide effective cardiac imaging for patients who have suspected or known myocardial infarction, a new pilot study has demonstrated.
In a poster presentation submitted to the International Society of Magnetic Resonance in Medicine virtual annual meeting, a team of cardiology investigators from the National Institutes of Health (NIH) described their use of 0.55T MRI to acquire and interpret late gadolinium enhancement (LGE) in possible heart attack patients.
Because high-field strength MRI has been known to increase artifact in cardiac imaging, there is a push to develop low-field cardiac MRI, the team said.
“Our group has demonstrated that a lower field strength, paired with the high-performance hardware and contemporary imaging software, may be well suited to cardiac imaging,” said the team led by W. Patricia Bandettini, M.D., associate research physician at the NIH. “Our pilot investigation demonstrates that demanding imaging techniques, such as late gadolinium enhancement imaging, are feasible at 0.55T.”
Successful implementation of this approach could not only reduce costs, the team said, but it could also increase accessibility to cardiac MR imaging.
To determine the comparative difference between both types of imaging strengths, the team assessed 13 patients for known or suspected myocardial infarction with both 0.55T and 1.5T MRI. The investigators intravenously administered gadobutrol and performed LGE imaging after 10 minutes.
For imaging analysis, LGE sequences selected and optimized for each field strength on a 17-segment model. They used the identification of abnormal LGE consistent with myocardial infarction, as well as additional grading of the coronary distribution – whether the myocardial infarction was less than or more than 50 percent transmural extent – for scoring.
According to their evaluations, the number of segments identified between each field strength was comparable. The 0.55T scanner identified 59 segments with myocardial infarction (50 subendocardial and nine transmural), and the 1.5T scanner detected 63 segments with myocardial infarction (53 subendocardial and 10 transmural). In addition, the team said, epicardial coronary artery distribution matched exactly between the two field strengths.
The team plans to expand their work with future studies that include free-breathing acquisition methods.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
Can Deep Learning Ultra-Fast bpMRI Have an Impact in Prostate Cancer Imaging?
March 3rd 2025A deep learning-enhanced ultra-fast bpMRI protocol offered similar sensitivity for csPCa as mpMRI with an 80 percent reduction in scan time, according to research findings presented at the European Congress of Radiology (ECR) conference.